Results 251 to 260 of about 83,934 (302)
Some of the next articles are maybe not open access.
Practical Neurology, 2021
Visual hallucinations have intrigued neurologists and physicians for generations due to patients’ vivid and fascinating descriptions. They are most commonly associated with Parkinson’s disease and dementia with Lewy bodies, but also occur in people with visual loss, where they are known as Charles Bonnet syndrome. More rarely, they can develop in other
Rimona S Weil, A J Lees
openaire +3 more sources
Visual hallucinations have intrigued neurologists and physicians for generations due to patients’ vivid and fascinating descriptions. They are most commonly associated with Parkinson’s disease and dementia with Lewy bodies, but also occur in people with visual loss, where they are known as Charles Bonnet syndrome. More rarely, they can develop in other
Rimona S Weil, A J Lees
openaire +3 more sources
WIREs Cognitive Science, 2010
AbstractUnderstanding of visual hallucinations is developing rapidly. Single‐factor explanations based on specific pathologies have given way to complex multifactor models with wide potential applicability. Clinical studies of disorders with frequent hallucinations—dementia, delirium, eye disease and psychosis—show that dysfunction within many parts of
Daniel, Collerton, Urs Peter, Mosimann
openaire +2 more sources
AbstractUnderstanding of visual hallucinations is developing rapidly. Single‐factor explanations based on specific pathologies have given way to complex multifactor models with wide potential applicability. Clinical studies of disorders with frequent hallucinations—dementia, delirium, eye disease and psychosis—show that dysfunction within many parts of
Daniel, Collerton, Urs Peter, Mosimann
openaire +2 more sources
Current Treatment Options in Neurology, 2004
Neurologists and ophthalmologists should be familiar with the causes and treatment of visual hallucinations so that they are able to reassure patients and minimize the anguish associated with untreated visual hallucinations. Hallucinations are under-reported by patients because of the perceived psychiatric implication or because of poor insight into ...
Victoria S., Pelak, Grant T., Liu
openaire +2 more sources
Neurologists and ophthalmologists should be familiar with the causes and treatment of visual hallucinations so that they are able to reassure patients and minimize the anguish associated with untreated visual hallucinations. Hallucinations are under-reported by patients because of the perceived psychiatric implication or because of poor insight into ...
Victoria S., Pelak, Grant T., Liu
openaire +2 more sources
Clarithromycin-Induced Visual Hallucinations
Neuro-Ophthalmology, 2022An independent 90-year-old woman presented to hospital with vivid and dynamic visual hallucinations following initiation of clarithromycin therapy. She had a background of previous cataract removal with good visual resolution and no significant deficits in visual acuity. Notably, she had been taking sertraline and quinine concurrently.
Daragh, McGee +3 more
openaire +2 more sources
Hypnotically Induced Visual Hallucinations
Psychosomatic Medicine, 1966Hypnotized subjects who reported vivid hallucinations of a visual situation which would ordinarily elicit optokinetic nystagmus (e.g., gazing at a rotating drum having vertical black and white stripes) demonstrated nystagmus under these conditions.
J P, Brady, E E, Levitt
openaire +2 more sources
Visual hallucinations in ophthalmology
Graefe's Archive for Clinical and Experimental Ophthalmology, 1987Forty-three patients with severe visual impairment due to bilateral eye disease were assessed for visual hallucinations, 28 of them after eye surgery. Ages ranged between 65 and 93 years and none of the patients had any psychiatric disorder. Five of the 43 patients were diagnosed as cases with Charles Bonnet syndrome reporting visual hallucinations ...
H M, Olbrich +3 more
openaire +2 more sources
Methylphenidate-Induced Visual Hallucinations
Neuropediatrics, 2011An 11-year-old boy with attention deficit/hyperactivity disorder (ADHD) presented with visual hallucinations several years after starting methylphenidate (MPH). The hallucinations resolved upon discontinuation of the drug. Reports of toxic hallucinosis during treatment with MPH are rare. Although the pathogenetic mechanism is unclear, the occurrence of
Porfirio, MC +3 more
openaire +3 more sources
Prevalence of visual hallucinations
Clinical and Experimental Optometry, 2020To determine the prevalence of visual hallucinations and to report its associations with demographic and clinical factors in a population-based survey in India.Prevalence of visual hallucinations was determined as a part of a large prospective, cross-sectional, population-based study that was carried out in two districts of Telangana, namely Khammam ...
Srinivas, Marmamula +4 more
openaire +2 more sources
Doxepin and Visual Hallucinations
Australian & New Zealand Journal of Psychiatry, 1982(1982). Doxepin and Visual Hallucinations. Australian and New Zealand Journal of Psychiatry: Vol. 16, No. 4, pp. 295-296.
T R, Norman +3 more
openaire +2 more sources
Complex nocturnal visual hallucinations
Sleep Medicine, 2005To describe the clinical features and associations of complex nocturnal visual hallucinations.We identified 12 patients seen between 1997 and 2004 with complex nocturnal visual hallucinations. Charts were reviewed and data analyzed.Of the 12 patients, 11 were women.
Michael H, Silber +2 more
openaire +2 more sources